Patents/Assignees

DEKA BIOSCIENCES, Inc.

19 patents in portfolio

US12552849utility2026
Method of Reducing Bispecific T Cell Engager or Chimeric Antigen Receptor T Cell Mediated Cytokine Release Syndrome Using Interleukins-4, -10, or a Fusion Protein Thereof
0 cites
US12268903utility2025
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12263358utility2025
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12145007utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12121755utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12122814utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12116389utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12116390utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12116391utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12116392utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12116393utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12110317utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12065473utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US12006346utility2024
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US11629178utility2023
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US11618775utility2023
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US11613563utility2023
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US11608368utility2023
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites
US11572397utility2023
Dual Cytokine Fusion Proteins Comprising IL-10
0 cites